Relationship of the pulmonary disease severity scoring with thromboembolic complications in COVID-19

Affiliations

01 February 2022

-

doi: 10.1007/s10140-021-01998-z


Abstract

Purpose: To correlate thromboembolic (TE) complications secondary to COVID-19 with the extent of the pulmonary parenchymal disease using CT severity scores and other comorbidities.

Methods: In total, 185 patients with COVID-19 and suspected thromboembolic complications were classified into two groups based on the presence or absence of thromboembolic complications. Thromboembolic complications were categorized based on location. Chest CT severity scoring system was used to assess the pulmonary parenchymal disease severity in all patients. Based into severity scores, patients were categorized into three groups (mild, moderate, and sever disease).

Results: The final study cohort consisted of 171 patients (99 male and 72 female) after excluding 14 patients with non-diagnostic CT pulmonary angiography. The TE group included 53 patients with a mean age of 55.1 ± 7.1, while the non-TE group included 118 patients with a mean age of 52.9 ± 10.8. Patients with BMI > 30 kg/m2 or having a history of smoking and HTN were found more frequently in the TE group (p < 0.05). Patients admitted to ICU were significantly higher in the TE group (p < 0.001). There was statistically significant difference (p = 0.002) in chest CT-SS between the TE group (22.8 ± 11.4) and non-TE group (17.6 ± 10.7). The percentage of severe parenchymal disease in the TE group was significantly higher compared to the non-TE group (p < 0.05). Severe parenchymal disease, BMI > 30 kg/m2, smoking, and HTN had a higher and more significant odds ratio for developing TE complications.

Conclusion: The present data suggest that severe pulmonary parenchymal disease secondary to COVID-19 is associated with a higher incidence of thromboembolic complications.

Keywords: COVID-19; Coronavirus; Embolism; Ischemia; SARS-COV-2; Thrombosis.


Figures


Similar articles

Extent of pulmonary thromboembolic disease in patients with COVID-19 on CT: relationship with pulmonary parenchymal disease.

Fang C, Garzillo G, Batohi B, Teo JTH, Berovic M, Sidhu PS, Robbie H.Clin Radiol. 2020 Oct;75(10):780-788. doi: 10.1016/j.crad.2020.07.002. Epub 2020 Jul 10.PMID: 32684301 Free PMC article.

Pulmonary thromboembolic disease in COVID-19 patients on CT pulmonary angiography - Prevalence, pattern of disease and relationship to D-dimer.

Ooi MWX, Rajai A, Patel R, Gerova N, Godhamgaonkar V, Liong SY.Eur J Radiol. 2020 Nov;132:109336. doi: 10.1016/j.ejrad.2020.109336. Epub 2020 Oct 6.PMID: 33069986 Free PMC article.

[Parenchymal lung changes on CT in patients with coronavirus disease 2019 (COVID-19)].

Halldorsson AB, Axelsson GT, Jonsson HM, Isaksson JD, Hardardottir H, Gudmundsson G, Hansdottir S.Laeknabladid. 2021 Oct;107(10):460-468. doi: 10.17992/lbl.2021.10.655.PMID: 34585672 Icelandic.

A Review of the Prevalence of Thromboembolic Complications among Pregnant Women Infected with COVID-19.

Mohd Ariff NS, Abdul Halim Zaki I, Mohd Noordin Z, Md Hussin NS, Goh KW, Ming LC, Zulkifly HH.J Clin Med. 2022 Oct 8;11(19):5934. doi: 10.3390/jcm11195934.PMID: 36233801 Free PMC article. Review.

Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia.

Li J, He X, Yuan Yuan, Zhang W, Li X, Zhang Y, Li S, Guan C, Gao Z, Dong G.Am J Infect Control. 2021 Jan;49(1):82-89. doi: 10.1016/j.ajic.2020.06.008. Epub 2020 Jun 12.PMID: 32540370 Free PMC article. Review.


References

  1.  
    1. Hui DS, Azhar EI, Madani TA, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264–266. - PMC - PubMed
  2.  
    1. WHO. Noval coronavirus Feb 11, 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situationreports/20...
  3.  
    1. Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–23. - PMC - PubMed
  4.  
    1. Zhu N, Zhang D, Wang W. China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China. N Engl J Med. 2020;382(8):727–733. - PMC - PubMed
  5.  
    1. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013;13(9):752–761. - PMC - PubMed
  6.  
    1. Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348(20):1986–1994. - PubMed
  7.  
    1. Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan. Italy Thromb Res. 2020;191:9–14. - PMC - PubMed
  8.  
    1. Vernuccio F, Lombardo FP, Cannella R, et al. Thromboembolic complications of COVID-19: the combined effect of a pro-coagulant pattern and an endothelial thrombo-inflammatory syndrome. Clin Radiol. 2020;75(11):804–810. - PMC - PubMed
  9.  
    1. Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood J Am Soc Hematol. 2020;135(23):2033–2040. - PMC - PubMed
  10.  
    1. Llitjos JF, Leclerc M, Chochois C, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020;18:1743–1746. - PMC - PubMed
  11.  
    1. Kruse JM, Magomedov A, Kurreck A, Münch FH, Koerner R, Kamhieh-Milz J, Kahl A, Gotthardt I, Piper SK, Eckardt KU, Dörner T, Zickler D. Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis. Crit Care. 2020;24(1):676. - PMC - PubMed
  12.  
    1. Elmokadem AH, Batouty NM, Bayoumi D, Gadelhak BN, Abdel-Wahab RM, Zaky M et al (2021) Mimickers of novel coronavirus disease 2019 (COVID-19) on chest CT: spectrum of CT and clinical features. Insights Imaging [Internet];12(1):12. Available from: 10.1186/s13244-020-00956-6 - PMC - PubMed
  13.  
    1. Elmokadem AH, Bayoumi D, Abo-Hedibah SA, El-Morsy A. Diagnostic performance of chest CT in differentiating COVID-19 from other causes of ground-glass opacities. Egypt J Radiol Nucl Med. 2021;52(1):1–10.
  14.  
    1. Yang R, Li X, Liu H, Zhen Y, Zhang X, Xiong Q, et al. Chest CT severity score: an imaging tool for assessing severe COVID-19. Radiol Cardiothorac Imaging. 2020;2(2):e200047. - PMC - PubMed
  15.  
    1. Abo-Hedibah SA, Tharwat N, Elmokadem AH. Is chest X-ray severity scoring for COVID-19 pneumonia reliable? Pol J Radiol. 2021;86:e432–e439. - PMC - PubMed
  16.  
    1. Espallargas I, Sevilla JJR, Chiaradía DAR, Salar A, Casamayor G, Villar-Garcia J, et al. CT imaging of pulmonary embolism in patients with COVID-19 pneumonia: a retrospective analysis. Eur Radiol. 2021;31(4):1915–1922. - PMC - PubMed
  17.  
    1. Fang C, Garzillo G, Batohi B, Teo J, Berovic M, Sidhu P, et al. Extent of pulmonary thromboembolic disease in patients with COVID-19 on CT: relationship with pulmonary parenchymal disease. Clin Radiol. 2020;75(10):780–788. - PMC - PubMed
  18.  
    1. Patel BV, Arachchillage DJ, Ridge CA, Bianchi P, Doyle JF, Garfield B, et al. Pulmonary angiopathy in severe COVID-19: physiologic, imaging, and hematologic observations. Am J Respir Crit Care Med. 2020;202(5):690–699. - PMC - PubMed
  19.  
    1. Cai Q, Chen F, Wang T, Luo F, Liu X, Wu Q, et al. Obesity and COVID-19 severity in a designated hospital in Shenzhen. China Diabetes care. 2020;43(7):1392–1398. - PubMed
  20.  
    1. Di Minno A, Ambrosino P, Calcaterra I, Di Minno MND. COVID-19 and venous thromboembolism: a meta-analysis of literature studies. Semin Thromb Hemost. 2020;46(7):763–771. - PMC - PubMed
  21.  
    1. Llitjos JF, Leclerc M, Chochois C, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020;18(7):1743–1746. - PMC - PubMed
  22.  
    1. Mestre-Gómez B, Lorente-Ramos RM, Rogado J, et al. Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis. J Thromb Thrombolysis. 2021;51(1):40–46. - PMC - PubMed
  23.  
    1. Poyiadji N, Cormier P, Patel PY, Hadied MO, Bhargava P, Khanna K, Nadig J, Keimig T, Spizarny D, Reeser N, Klochko C, Peterson EL, Song T. Acute pulmonary embolism and COVID-19. Radiology. 2020;297(3):E335–E338. doi: 10.1148/radiol.2020201955. - DOI - PMC - PubMed
  24.  
    1. Myers LC, Parodi SM, Escobar GJ, Liu VX. Characteristics of hospitalized adults with COVID-19 in an integrated health care system in California. JAMA. 2020;323(21):2195–2198. - PMC - PubMed
  25.  
    1. Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G. Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence. J Clin Med. 2020;9(5):1417. doi: 10.3390/jcm9051417. - DOI - PMC - PubMed
  26.  
    1. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–147. - PMC - PubMed
  27.  
    1. Roncon L, Zuin M, Barco S, Valerio L, Zuliani G, Zonzin P, et al. Incidence of acute pulmonary embolism in COVID-19 patients: systematic review and meta-analysis. Eur J Intern Med. 2020;82:29–37. - PMC - PubMed
  28.  
    1. Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol. 2020;127:104362. - PMC - PubMed
  29.  
    1. Chen J, Wang X, Zhang S, Lin B, Wu X, Wang Y, et al. Characteristics of acute pulmonary embolism in patients With COVID-19 associated pneumonia from the city of Wuhan. Clin Appl Thromb Hemost. 2020;26:1076029620936772. - PMC - PubMed
  30.  
    1. Demelo-Rodríguez P, Cervilla-Muñoz E, Ordieres-Ortega L, Parra-Virto A, Toledano-Macías M, Toledo-Samaniego N, et al. Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels. Thromb Res. 2020;192:23–26. - PMC - PubMed
  31.  
    1. Naymagon L, Zubizarreta N, Feld J, van Gerwen M, Alsen M, Thibaud S, et al. Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19. Thromb Res. 2020;196:99–105. - PMC - PubMed
  32.  
    1. Price LC, McCabe C, Garfield B, Wort SJ. Thrombosis and COVID-19 pneumonia: the clot thickens! Eur Respir J. 2020;56(1):2001608. - PMC - PubMed
  33.  
    1. Bompard F, Monnier H, Saab I, Tordjman M, Abdoul H, Fournier L, Sanchez O, Lorut C, Chassagnon G, Revel MP. Pulmonary embolism in patients with COVID-19 pneumonia. Eur Respir J. 2020;56(1):2001365. doi: 10.1183/13993003.01365-2020. - DOI - PMC - PubMed
  34.  
    1. van Dam LF, Kroft LJM, van der Wal LI, Cannegieter SC, Eikenboom J, de Jonge E, et al. Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: a different phenotype of thrombotic disease? Thromb Res. 2020;193:86–89. - PMC - PubMed
  35.  
    1. Mueller-Peltzer K, Krauss T, Benndorf M, Lang CN, Bamberg F, Bode C, et al. Pulmonary artery thrombi are co-located with opacifications in SARS-CoV2 induced ARDS. Respir Med. 2020;172:106135. - PMC - PubMed
  36.  
    1. Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med. 2020;382(20):e60. - PMC - PubMed
  37.  
    1. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan. China JAMA Neurol. 2020;77(6):683–690. - PMC - PubMed
  38.  
    1. Belani P, Schefflein J, Kihira S, Rigney B, Delman BN, Mahmoudi K, et al. COVID-19 is an independent risk factor for acute ischemic stroke. AJNR Am J Neuroradiol. 2020;41(8):1361–1364. - PMC - PubMed
  39.  
    1. Beyrouti R, Adams ME, Benjamin L, Cohen H, Farmer SF, Goh YY, et al. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 2020;91(8):889–891. - PMC - PubMed
  40.  
    1. Avula A, Nalleballe K, Narula N, Sapozhnikov S, Dandu V, Toom S, et al. COVID-19 presenting as stroke. Brain Behav Immun. 2020;87:115–119. - PMC - PubMed
  41.  
    1. Tan YK, Goh C, Leow AST, Tambyah PA, Ang A, Yap ES, et al. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. J Thromb Thrombolysis. 2020;50(3):587–595. - PMC - PubMed
  42.  
    1. Norsa L, Valle C, Morotti D, Bonaffini PA, Indriolo A, Sonzogni A. Intestinal ischemia in the COVID-19 era. Dig Liver Dis. 2020;52(10):1090–1091. - PMC - PubMed
  43.  
    1. Parry AH, Wani AH, Yaseen M. Acute mesenteric ischemia in severe coronavirus-19 (COVID-19): possible mechanisms and diagnostic pathway. Acad Radiol. 2020;27(8):1190. - PMC - PubMed
  44.  
    1. Fan BE. COVID-19-associated thromboembolic events causing acute mesenteric ischaemia. Acad Radiol. 2020;27(12):1788–1789. - PMC - PubMed
  45.  
    1. Cheung S, Quiwa JC, Pillai A, Onwu C, Tharayil ZJ, Gupta R. Superior mesenteric artery thrombosis and acute intestinal ischemia as a consequence of COVID-19 infection. Am J Case Rep. 2020;21:e925753. - PMC - PubMed
  46.  
    1. Santos Leite Pessoa M, Franco Costa Lima C, Farias Pimentel AC, Godeiro Costa JC, BezerraHolanda JL. Multisystemic infarctions in COVID-19: focus on the spleen. Eur J Case Rep Intern Med. 2020;7(7):001747. - PMC - PubMed
  47.  
    1. Goldman IA, Ye K, Scheinfeld MH. Lower-extremity arterial thrombosis associated with COVID-19 is characterized by greater thrombus burden and increased rate of amputation and death. Radiology. 2020;297(2):E263–E269. - PMC - PubMed
  48.  
    1. Besutti G, Bonacini R, Iotti V, Marini G, Riva N, Dolci G, et al. Abdominal visceral infarction in 3 patients with COVID-19. Emerg Infect Dis. 2020;26(8):1926–1928. - PMC - PubMed
  49.  
    1. Azouz E, Yang S, Monnier-Cholley L, Arrivé L. Systemic arterial thrombosis and acute mesenteric ischemia in a patient with COVID-19. Intensive Care Med. 2020;46(7):1464–1465. - PMC - PubMed